Market Cap 776.60M
Revenue (ttm) 0.00
Net Income (ttm) -190.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 6,515,300
Avg Vol 10,799,010
Day's Range N/A - N/A
Shares Out 345.16M
Stochastic %K 85%
Beta 0.46
Analysts Strong Sell
Price Target $8.49

Company Profile

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is also developing cemacabtagene ansegedleucel (cema-cel), an engineered allogeneic CAR T...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 457 2700
Address:
210 East Grand Avenue, South San Francisco, United States
Expharmaguy
Expharmaguy May. 29 at 4:12 PM
$ALLO In my opinion, nothing changes with Dr. Chang stepping down as CEO, and Dr. Z Roberts taking over. Dr. Chang remains on the BOD, but if you have been invested in ALLO for the last several yrs, Dr. Roberts is highly qualified and very competent to see that their programs meet their milestones!
0 · Reply
Paraboljoker
Paraboljoker May. 29 at 4:08 PM
$RAVE.X i want to be hangover af on sunday 100x 🕺🐣💊 $ALLO $PEPE.X @binance @coinbase $COIN $BNB.X
1 · Reply
seandevil96
seandevil96 May. 29 at 2:49 PM
$ALLO how many more bad beats can you dish out $ALLO ?
0 · Reply
boomshiva
boomshiva May. 29 at 2:34 PM
$ALLO Well, damn.
0 · Reply
focafoca99
focafoca99 May. 28 at 9:24 PM
$ALLO transitioned its leadership as David Chang steps down and Zach Roberts takes over as CEO.
0 · Reply
focafoca99
focafoca99 May. 28 at 9:17 PM
$ALLO installed Zachary Roberts as its new President and CEO, with a $680K base salary and equity awards, effective July 1, 2026.
0 · Reply
x_pressionist
x_pressionist May. 28 at 2:54 PM
$ALLO Need a little volume and a push above 2.32. Let’s do it!
0 · Reply
x_pressionist
x_pressionist May. 27 at 9:50 PM
$ALLO We had a very good day, but it needs to close above 2.30/2.32 on strong volume to break out of this rut.
0 · Reply
JBuyer
JBuyer May. 27 at 5:50 PM
$ALLO https://www.marketbeat.com/stocks/NASDAQ/ALLO/short-interest/
0 · Reply
JBuyer
JBuyer May. 27 at 5:50 PM
$ALLO This is why all casino type activities engaged by young irresponsible traders on the gaming computers fro their moms basement- should be restricted to the new polly-markets and not allowed to strip-mine the shares of research companies like this one -,who are developing cures for deadly diseases. 😎👍
0 · Reply
Latest News on ALLO
Allogene Therapeutics Announces Planned CEO Succession

May 28, 2026, 5:02 PM EDT - 20 hours ago

Allogene Therapeutics Announces Planned CEO Succession


Allogene Therapeutics Proxy statement: Proxy filing

May 28, 2026, 8:00 AM EDT - 1 day ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Proxy statement: Proxy filing

May 21, 2026, 8:00 AM EDT - 8 days ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Slides: Corporate presentation

May 16, 2026, 7:00 AM EDT - 13 days ago

Allogene Therapeutics Slides: Corporate presentation


Allogene Therapeutics Q1 Earnings Call Highlights

May 13, 2026, 8:15 PM EDT - 15 days ago

Allogene Therapeutics Q1 Earnings Call Highlights


Allogene Therapeutics reports Q1 EPS (18c), consensus (18c)

2026-05-13T21:04:53.000Z - 15 days ago

Allogene Therapeutics reports Q1 EPS (18c), consensus (18c)


Allogene Therapeutics Earnings Call Transcript: Q1 2026

May 13, 2026, 5:00 PM EDT - 15 days ago

Allogene Therapeutics Earnings Call Transcript: Q1 2026


Allogene Therapeutics Earnings release: Q1 2026

May 13, 2026, 5:00 PM EDT - 15 days ago

Allogene Therapeutics Earnings release: Q1 2026


Allogene Therapeutics Quarterly report: Q1 2026

May 13, 2026, 5:00 PM EDT - 15 days ago

Allogene Therapeutics Quarterly report: Q1 2026


Allogene Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 weeks ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 weeks ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 5 weeks ago

Allogene Therapeutics Proxy statement: Proxy filing


Allogene Therapeutics announces $175M common stock offering

2026-04-13T20:35:10.000Z - 6 weeks ago

Allogene Therapeutics announces $175M common stock offering


Allogene Therapeutics Transcript: Study result

Apr 13, 2026, 8:30 AM EDT - 6 weeks ago

Allogene Therapeutics Transcript: Study result


Allogene Therapeutics Press release: Study result

Apr 13, 2026, 8:30 AM EDT - 6 weeks ago

Allogene Therapeutics Press release: Study result


Allogene Therapeutics Slides: Study result

Apr 13, 2026, 8:30 AM EDT - 6 weeks ago

Allogene Therapeutics Slides: Study result


Allogene Therapeutics Earnings Call Transcript: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 2 months ago

Allogene Therapeutics Earnings Call Transcript: Q4 2025


Allogene Therapeutics Annual report: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 2 months ago

Allogene Therapeutics Annual report: Q4 2025


Allogene Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 2 months ago

Allogene Therapeutics Earnings release: Q4 2025


Allogene Therapeutics Slides: Corporate presentation

Mar 12, 2026, 4:00 PM EDT - 2 months ago

Allogene Therapeutics Slides: Corporate presentation


Allogene Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

Allogene Therapeutics Earnings Call Transcript: Q3 2025


Allogene Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

Allogene Therapeutics Quarterly report: Q3 2025


Allogene Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

Allogene Therapeutics Earnings release: Q3 2025


Allogene Therapeutics Transcript: Citi's SMID Call Series 2025

Oct 2, 2025, 1:00 PM EDT - 8 months ago

Allogene Therapeutics Transcript: Citi's SMID Call Series 2025


Allogene Therapeutics Earnings Call Transcript: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 10 months ago

Allogene Therapeutics Earnings Call Transcript: Q2 2025


Allogene Therapeutics Quarterly report: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 10 months ago

Allogene Therapeutics Quarterly report: Q2 2025


Allogene Therapeutics Earnings release: Q2 2025

Aug 13, 2025, 5:00 PM EDT - 10 months ago

Allogene Therapeutics Earnings release: Q2 2025


Allogene Therapeutics Transcript: Study Result

Aug 1, 2025, 11:00 AM EDT - 10 months ago

Allogene Therapeutics Transcript: Study Result


Allogene Therapeutics Press release: Study Result

Aug 1, 2025, 11:00 AM EDT - 10 months ago

Allogene Therapeutics Press release: Study Result


Allogene Therapeutics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

Allogene Therapeutics Slides: Corporate Presentation


Allogene Therapeutics Earnings Call Transcript: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q1 2025


Allogene Therapeutics Quarterly report: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Quarterly report: Q1 2025


Allogene Therapeutics Earnings release: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings release: Q1 2025


Allogene Therapeutics Slides: Corporate Presentation

May 12, 2025, 6:00 PM EDT - 1 year ago

Allogene Therapeutics Slides: Corporate Presentation


Allogene Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Allogene Therapeutics Proxy statement: Proxy Filing


Allogene Therapeutics Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Allogene Therapeutics Proxy statement: Proxy Filing


Allogene Therapeutics Earnings Call Transcript: Q4 2024

Mar 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q4 2024


Allogene Therapeutics Annual report: Q4 2024

Mar 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Annual report: Q4 2024


Allogene Therapeutics Earnings release: Q4 2024

Mar 13, 2025, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings release: Q4 2024


Allogene Therapeutics Slides: FY 2025

Jan 15, 2025, 6:00 PM EST - 1 year ago

Allogene Therapeutics Slides: FY 2025


Allogene Therapeutics Slides: Corporate Presentation

Jan 12, 2025, 6:00 PM EST - 1 year ago

Allogene Therapeutics Slides: Corporate Presentation


Allogene Therapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q3 2024


Allogene Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Allogene Therapeutics Quarterly report: Q3 2024


Allogene Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Allogene Therapeutics Earnings release: Q3 2024


Allogene Therapeutics Earnings Call Transcript: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings Call Transcript: Q2 2024


Allogene Therapeutics Quarterly report: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Quarterly report: Q2 2024


Allogene Therapeutics Earnings release: Q2 2024

Aug 7, 2024, 5:00 PM EDT - 1 year ago

Allogene Therapeutics Earnings release: Q2 2024


Expharmaguy
Expharmaguy May. 29 at 4:12 PM
$ALLO In my opinion, nothing changes with Dr. Chang stepping down as CEO, and Dr. Z Roberts taking over. Dr. Chang remains on the BOD, but if you have been invested in ALLO for the last several yrs, Dr. Roberts is highly qualified and very competent to see that their programs meet their milestones!
0 · Reply
Paraboljoker
Paraboljoker May. 29 at 4:08 PM
$RAVE.X i want to be hangover af on sunday 100x 🕺🐣💊 $ALLO $PEPE.X @binance @coinbase $COIN $BNB.X
1 · Reply
seandevil96
seandevil96 May. 29 at 2:49 PM
$ALLO how many more bad beats can you dish out $ALLO ?
0 · Reply
boomshiva
boomshiva May. 29 at 2:34 PM
$ALLO Well, damn.
0 · Reply
focafoca99
focafoca99 May. 28 at 9:24 PM
$ALLO transitioned its leadership as David Chang steps down and Zach Roberts takes over as CEO.
0 · Reply
focafoca99
focafoca99 May. 28 at 9:17 PM
$ALLO installed Zachary Roberts as its new President and CEO, with a $680K base salary and equity awards, effective July 1, 2026.
0 · Reply
x_pressionist
x_pressionist May. 28 at 2:54 PM
$ALLO Need a little volume and a push above 2.32. Let’s do it!
0 · Reply
x_pressionist
x_pressionist May. 27 at 9:50 PM
$ALLO We had a very good day, but it needs to close above 2.30/2.32 on strong volume to break out of this rut.
0 · Reply
JBuyer
JBuyer May. 27 at 5:50 PM
$ALLO https://www.marketbeat.com/stocks/NASDAQ/ALLO/short-interest/
0 · Reply
JBuyer
JBuyer May. 27 at 5:50 PM
$ALLO This is why all casino type activities engaged by young irresponsible traders on the gaming computers fro their moms basement- should be restricted to the new polly-markets and not allowed to strip-mine the shares of research companies like this one -,who are developing cures for deadly diseases. 😎👍
0 · Reply
MikeyNJ
MikeyNJ May. 27 at 4:05 PM
$ALLO remain very bullish on this one based on recent data. This should be significantly higher and would have been if not for the head scratching raise at $2. They had a cash runway into 2028. What was the rush to raise additional capital at such a discounted valuation? It makes many think that the company is not confident going forward and it is creating a headwind against the share price. The offering was oversubscribed which indicates the institutions liked the deal. So, I guess for those who are bullish, it creates an opportunity to buy. In the end, it all comes down to the future data anyway.
1 · Reply
Unburdened
Unburdened May. 27 at 2:16 PM
$ALLO OK, maybe we get some movement back to high $2's
0 · Reply
kaoz
kaoz May. 27 at 1:44 PM
$ALLO holding for 4
0 · Reply
kaoz
kaoz May. 27 at 1:34 PM
$ALLO $4 stock
0 · Reply
peanuta
peanuta May. 26 at 9:48 PM
$ALLO charles pane is a nozz. so is cramer.
0 · Reply
peanuta
peanuta May. 26 at 9:47 PM
$ALLO june is the month of sha-bang-ka-pow. right? sha-bang-ka-paw
0 · Reply
StijnRR
StijnRR May. 26 at 7:49 PM
0 · Reply
BioFlare
BioFlare May. 21 at 10:18 PM
$ALLO Yeah sucks…gotta drop it even more!!! Ill try to not buy any lol
0 · Reply
Unburdened
Unburdened May. 21 at 8:07 PM
$ALLO Damn did we really close green? The recent bag holders from the equity raise debacle must be proud.
1 · Reply
alwayscheaper
alwayscheaper May. 21 at 1:33 PM
$ALLO another big dump right at the opening
0 · Reply
BraSJ
BraSJ May. 21 at 12:17 PM
$ALLO it will actually be live event here today ??
1 · Reply
kaoz
kaoz May. 20 at 8:39 PM
$ALLO Entered today. Easy up from here.
0 · Reply